CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (4,807,062)	$ (2,662,741)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	97,412	75,067
Loss on extinguishment of debt	1,774,662	0
Stock-based compensation	571,498	205,490
Amortization of debt issuance costs	0	6,157
Change in operating assets and liabilities:
Accounts receivable	(840,035)	565,982
Inventories	(46,096)	59,946
Prepaid expenses and other current assets and deposits	(121,850)	(13,337)
Accounts payable and accrued liabilities	(638,066)	(793,895)
Deferred revenue	(146,205)	(173,942)
Net cash used in operating activities	(4,155,742)	(2,731,273)
Cash flows from investing activities:
Purchase of property and equipment	(329,542)	0
Net cash used in investing activities	(329,542)	0
Cash flows from financing activities:
Repayment of secured convertible notes payable	(1,665,581)	(107,802)
Net proceeds from exercise of warrants	2,605,529	0
Net proceeds from sale of common stock and warrants	0	10,942,940
Net cash provided by financing activities	939,948	10,835,138
Net (decrease) increase in cash and cash equivalents	(3,545,336)	8,103,865
Cash and cash equivalents at beginning of year	7,786,743	558,988
Cash and cash equivalents at end of year	4,241,407	8,662,853
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest	0	0
Cash paid during period for income taxes	0	0
Non-cash investing and financing activities:
Interest paid in kind	35,243	35,625
Property and equipment acquired, and included in accounts payable	641,979	0
Deemed dividend-warrant repricing	0	2,842
Deferred offering costs reclassified to additional paid in capital	0	109,698
Public offering costs included in accounts payable and accrued liabilities	0	303,212
FV of warrants issued	$ 1,074,118	$ 0